Can a new drug and probiotic combo turn back the clock on aging?
NCT ID NCT07363057
Summary
This study is testing whether a combination of an investigational drug (GI-102) and a probiotic blend (GIB-7) can improve certain biological signs of aging. It will involve about 15 healthy adults and cancer survivors, who will take the combination for 8 weeks. Researchers will measure changes in immune cells, muscle strength, sleep quality, and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novatrials
RECRUITINGCharlestown, New South Wales, 2290, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Southern Oncology Clinical Research Unit
RECRUITINGAdelaide, South Australia, 5042, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.